Your end-to-end CDMO partner
for your viral vector projects

We are a pure play CDMO, specialized in development and manufacturing of viral vectors.
From development to market, we provide GMP viral vectors, contributing to the success of our clients’ immunotherapies and gene therapy innovations.
Our European sites are GMP certified
AREAS OF
EXPERTISE
Vaccines

Vaccines

Oncolytic (Virotherapies)

Oncolytic (Virotherapies)

Other Immunotherapies

Other Immunotherapies

Gene therapy

We have been a pioneer in developing and producing viral vectors.

We are grounded in the Mérieux family’s legacy of biology and vaccine expertise since 1897.

As a pure CDMO player, we contribute to the success of your immunotherapy and gene therapy innovations.

OUR LATEST NEWS

Services

We support our customers’ viral vector projects
from Preclinical, Phase I, Phase II, Phase III up to Commercial